Literature DB >> 9113621

Phospholipid biosynthetic enzymes in human brain.

B M Ross1, A Moszczynska, J K Blusztajn, A Sherwin, A Lozano, S J Kish.   

Abstract

Growing evidence suggests an involvement of brain membrane phospholipid metabolism in a variety of neurodegenerative and psychiatric conditions. This has prompted the use of drugs (e.g., CDPcholine) aimed at elevating the rate of neural membrane synthesis. However, no information is available regarding the human brain enzymes of phospholipid synthesis which these drugs affect. Thus, the objective of our study was to characterize the enzymes involved, in particular, whether differences existed in the relative affinity of substrates for the enzymes of phosphatidylethanolamine (PE) compared to those of phosphatidylcholine (PC) synthesis. The concentration of choline in rapidly frozen human brain biopsies ranged from 32-186 nmol/g tissue, a concentration similar to that determined previously for ethanolamine. Since human brain ethanolamine kinase possessed a much lower affinity for ethanolamine (Km = 460 microM) than choline kinase did for choline (Km = 17 microM), the activity of ethanolamine kinase in vivo may be more dependent on substrate availability than that of choline kinase. In addition, whereas ethanolamine kinase was inhibited by choline, and to a lesser extent by phosphocholine, choline kinase activity was unaffected by the presence of ethanolamine, or phosphoethanolamine, and only weakly inhibited by phosphocholine. Phosphoethanolamine cytidylyltransferase (PECT) and phosphocholine cytidylyltransferase (PCCT) also displayed dissimilar characteristics, with PECT and PCCT being located predominantly in the cytosolic and particulate fractions, respectively. Both PECT and PCCT exhibited a low affinity for CTP (Km approximately 1.2 mM), suggesting that the activities of these enzymes, and by implication, the rate of phospholipid synthesis, are highly dependent upon the cellular concentration of CTP. In conclusion our data indicate different regulatory properties of PE and PC synthesis in human brain, and suggest that the rate of PE synthesis may be more dependent upon substrate (ethanolamine) availability than that of PC synthesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9113621     DOI: 10.1007/s11745-997-0044-x

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  42 in total

1.  Citicoline improves verbal memory in aging.

Authors:  P A Spiers; D Myers; G S Hochanadel; H R Lieberman; R J Wurtman
Journal:  Arch Neurol       Date:  1996-05

2.  Expression of wild-type and mutant rat liver CTP: phosphocholine cytidylyltransferase in a cytidylyltransferase-deficient Chinese hamster ovary cell line.

Authors:  T D Sweitzer; C Kent
Journal:  Arch Biochem Biophys       Date:  1994-05-15       Impact factor: 4.013

3.  The association of lipid activators with the amphipathic helical domain of CTP:phosphocholine cytidylyltransferase accelerates catalysis by increasing the affinity of the enzyme for CTP.

Authors:  W Yang; K P Boggs; S Jackowski
Journal:  J Biol Chem       Date:  1995-10-13       Impact factor: 5.157

4.  Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study.

Authors:  Y Tazaki; F Sakai; E Otomo; T Kutsuzawa; M Kameyama; T Omae; M Fujishima; A Sakuma
Journal:  Stroke       Date:  1988-02       Impact factor: 7.914

5.  Choline regulates phosphatidylethanolamine biosynthesis in isolated hamster heart.

Authors:  T A Zelinski; P C Choy
Journal:  J Biol Chem       Date:  1982-11-25       Impact factor: 5.157

6.  Effects of CDP-choline on the recovery of patients with head injury.

Authors:  V Calatayud Maldonado; J B Calatayud Pérez; J Aso Escario
Journal:  J Neurol Sci       Date:  1991-07       Impact factor: 3.181

7.  An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy.

Authors:  J A Stanley; P C Williamson; D J Drost; T J Carr; R J Rylett; A Malla; R T Thompson
Journal:  Arch Gen Psychiatry       Date:  1995-05

8.  Effect of cytidine on membrane phospholipid synthesis in rat striatal slices.

Authors:  V Savci; R J Wurtman
Journal:  J Neurochem       Date:  1995-01       Impact factor: 5.372

9.  Effect of choline deficiency on the enzymes that synthesize phosphatidylcholine and phosphatidylethanolamine in rat liver.

Authors:  W J Schneider; D E Vance
Journal:  Eur J Biochem       Date:  1978-04

10.  Multiple forms of the enzyme glycerophosphodiesterase are present in human brain.

Authors:  B M Ross; A L Sherwin; S J Kish
Journal:  Lipids       Date:  1995-12       Impact factor: 1.880

View more
  27 in total

1.  In vivo 31P MRS of human brain at high/ultrahigh fields: a quantitative comparison of NMR detection sensitivity and spectral resolution between 4 T and 7 T.

Authors:  Hongyan Qiao; Xiaoliang Zhang; Xiao-Hong Zhu; Fei Du; Wei Chen
Journal:  Magn Reson Imaging       Date:  2006-10-04       Impact factor: 2.546

Review 2.  Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses.

Authors:  Richard J Wurtman; Mehmet Cansev; Toshimasa Sakamoto; Ismael Ulus
Journal:  Nutr Rev       Date:  2010-12       Impact factor: 7.110

3.  Oral supplementation with docosahexaenoic acid and uridine-5'-monophosphate increases dendritic spine density in adult gerbil hippocampus.

Authors:  Toshimasa Sakamoto; Mehmet Cansev; Richard J Wurtman
Journal:  Brain Res       Date:  2007-09-21       Impact factor: 3.252

Review 4.  Synapse formation is enhanced by oral administration of uridine and DHA, the circulating precursors of brain phosphatides.

Authors:  R J Wurtman; M Cansev; I H Ulus
Journal:  J Nutr Health Aging       Date:  2009-03       Impact factor: 4.075

Review 5.  Synapse formation and cognitive brain development: effect of docosahexaenoic acid and other dietary constituents.

Authors:  Richard J Wurtman
Journal:  Metabolism       Date:  2008-10       Impact factor: 8.694

6.  Pyrazinamide-induced hepatotoxicity and gender differences in rats as revealed by a 1H NMR based metabolomics approach.

Authors:  He Zhao; Zhi-Hong Si; Ming-Hui Li; Lei Jiang; Yong-Hong Fu; Yue-Xiao Xing; Wei Hong; Ling-Yu Ruan; Pu-Ming Li; Jun-Song Wang
Journal:  Toxicol Res (Camb)       Date:  2016-10-05       Impact factor: 3.524

7.  Effects of α7 Nicotinic Receptor Activation on Cell Survival in Rat Organotypic Hippocampal Slice Cultures.

Authors:  Denise F Happ; R Andrew Tasker
Journal:  Neurotox Res       Date:  2017-12-22       Impact factor: 3.911

8.  Neurometabolic effects of ACTH on free amino compounds in opsoclonus-myoclonus syndrome.

Authors:  M R Pranzatelli; E D Tate; J M Crowley; B Toennies; M Creer
Journal:  Neuropediatrics       Date:  2008-11-07       Impact factor: 1.947

9.  Perinatal Phosphatidylcholine Supplementation and Early Childhood Behavior Problems: Evidence for CHRNA7 Moderation.

Authors:  Randal G Ross; Sharon K Hunter; M Camille Hoffman; Lizbeth McCarthy; Betsey M Chambers; Amanda J Law; Sherry Leonard; Gary O Zerbe; Robert Freedman
Journal:  Am J Psychiatry       Date:  2015-12-07       Impact factor: 18.112

10.  Perinatal choline effects on neonatal pathophysiology related to later schizophrenia risk.

Authors:  Randal G Ross; Sharon K Hunter; Lizbeth McCarthy; Julie Beuler; Amanda K Hutchison; Brandie D Wagner; Sherry Leonard; Karen E Stevens; Robert Freedman
Journal:  Am J Psychiatry       Date:  2013-03       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.